VC  Golden Pine Ventures

http://www.goldenpineventures.com





     Office Locations:

5517 Durham Chapel Hill Boulevard
Suite 1500
Durham, NC 27707
Phone: 919-282-1719

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Founded 2004, Golden Pine Ventures is a venture capital company that is focused on discovering and developing exceedingly rare technologies which can form the basis of promising biotechnology and biomedical companies. The company seeks out exciting new breakthrough technologies in the Research Triangle Park region of North Carolina, as well as other select locations in the Southeast. The Chairman of Golden Pine, Peter Meldrum, is a Director of Myriad Genetics, a publicly-traded biopharmaceutical company. Prior to his time at Myriad, Meldrum was President and Chief Executive Officer of Founder's Fund, Inc., a venture capital group specializing in the biotechnology industry.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Christopher S. Meldrum Managing Director
    James A. Severson Ph.D. Director
    John E. Hamer Ph.D. Director
    Peter D. Meldrum Chairman

     

    Portfolio companies include:


      Arcato Laboratories
        web link


      Catena Pharmaceuticals
        web link


      Exigent Pharmaceuticals
        web link


      Kylin Therapeutics
        web link


      Pique Therapeutics
        web link


     

    Recent News: